IART
IART
NASDAQ · Health Care

Integra Lifesciences Holding

$14.10
-0.40 (-2.76%)
Financial Highlights (FY 2026)
Revenue
1.62B
Net Income
-510,856,207
Gross Margin
56.6%
Profit Margin
-31.6%
Rev Growth
+1.6%
D/E Ratio
1.78
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.6% 56.6% 67.3% 67.3%
Operating Margin -30.2% -27.2% 16.1% 18.5%
Profit Margin -31.6% -30.0% 14.6% 15.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.62B 1.59B 284.27M 289.60M
Gross Profit 915.81M 901.12M 191.26M 194.85M
Operating Income -489,284,645 -433,293,496 45.76M 53.46M
Net Income -510,856,207 -452,396,522 41.42M 44.34M
Gross Margin 56.6% 56.6% 67.3% 67.3%
Operating Margin -30.2% -27.2% 16.1% 18.5%
Profit Margin -31.6% -30.0% 14.6% 15.3%
Rev Growth +1.6% +1.6% +23.9% +16.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 351.96M 351.96M 104.07M 110.88M
Total Equity 197.87M 197.87M 274.89M 305.05M
D/E Ratio 1.78 1.78 0.38 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -475,538,184 -444,515,669 83.90M 77.61M
Free Cash Flow 47.45M 57.75M